The Impact of Breath Exercises by Telemedicine in Patients Aged 8-18 Years With a Diagnosis of Asthma

Allergic Asthma Clinical Trial

— PHASTER  

Official title:

The Impact of Breath Exercises by Telemedicine in Patients Aged 8-18 Years With a Diagnosis of Asthma

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05749237
• Other study ID #: Phaster
• Status: Recruiting
• Phase: N/A
• Start date: February 3, 2023
• Est. completion date: August 30, 2023

Study information

• Verified date: February 2023
• Source: Istanbul University - Cerrahpasa (IUC)
• Contact: Ayca Kiykim
• Phone: +905423432245
• Email: ayca.kiykim[@]iuc.edu.tr
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this randomized, placebo controlled study is to evaluate the effect of respiratory exercises on asthma attack frequency, symptom and medication scores and quality of life of children with a diagnosis of asthma. Participants will be asked to perform respiratory exercises described at once in hospital at home regularly. Control group will comprised children with asthma without respiratory exercises.

Description:

At the beginning of the study anthropometric measurements, basal respiratory function assessment, drugs, demographic information, allergen sensitivity, asthma control levels and quality of life scales will be documented. Patients will be randomly divided into two groups; one group following respiratory exercises and relaxation exercises and the other following only relaxation exercises. Both groups will be called regularly to remind the exercises. The spirometric tests and asthma control forms will be reevaluated at the 3rd and 6th month at hospital. Peak flow meters will be given to patients to document PEF values during study.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: August 30, 2023
• Est. primary completion date: August 30, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 10 Years to 18 Years

Eligibility

Inclusion Criteria:

clinical diagnosis of allergic asthma allergic asthma severity step 1 or step 2 - Exclusion Criteria: asthmatic children more severe than step 2 other comorbid disorders involving respiratory system or neuromusculatory disorders -

Related Conditions & MeSH terms

• Allergic Asthma
• Asthma

Intervention

Other:
• respiratory exercises
respiratory exercises
• relaxation exercises
relaxation exercises

Locations

Country	Name	City	State
Turkey	Istanbul University-Cerrahpasa	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Istanbul University - Cerrahpasa (IUC)

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in asthma attack frequency	asthma attack frequency by home PEF records and questionnaire, spirometric measurements and symptom and medication scoring charts	at third and sixth months
Secondary	Quality of life questionnaire	increase quality of life	at third and sixth months